|
FDA Requests Additional Information Regarding AFREZZA(TM) in Complete Response …
MarketWatch (press release) The letter did not require any additional pre-marketing clinical studies in order for the FDA to complete its review of the NDA. As recommended by the FDA, … FDA Seeks Additional Information On MannKind's Insulin Therapy Afrezza – Update MannKind's Insulin Afrezza Fails to Win Approval |